Jacobson Pharma Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Public

  • Employees
  • 1,768

Employees

  • Stock Symbol
  • 02633

Stock Symbol

  • Investments
  • 9

  • Share Price
  • $0.11
  • (As of Friday Closing)

Jacobson Pharma General Information

Description

Jacobson Pharma Corp Ltd and its subsidiaries are principally engaged in the development, production, marketing, and sale of essential medicines and specialty drugs to both the public and private sectors. The Group's essential medicines portfolio covers various therapeutic categories such as cardiovascular, central nervous system, gastrointestinal, antidiabetic, respiratory, anti-infective, etc.; and the specialty drugs portfolio comprises biosimilars, oncology medications, and orphan drugs. Additionally, its veterinary health division supports veterinarians and veterinary clinics with several products in different therapeutic classes and pharmaceutical forms. Geographically, the Group derives maximum revenue from Hong Kong, and the rest from Macau, the Chinese Mainland, and other regions.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Unit 2313-18, 23/F, Tower 1 Millennium City 1
  • 388 Kwun Tong Road, Kwun Tong, Kowloon
  • Hong Kong
  • Hong Kong
+852 2267
Primary Industry
Holding Companies
Other Industries
Pharmaceuticals
Stock Exchange
HKG
Corporate Office
  • Unit 2313-18, 23/F, Tower 1 Millennium City 1
  • 388 Kwun Tong Road, Kwun Tong, Kowloon
  • Hong Kong
  • Hong Kong
+852 2267

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jacobson Pharma Stock Performance

As of 20-Nov-2026, Jacobson Pharma’s stock price is $0.11. Its current market cap is $227M with 2B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.11 $0.11 $0.11 - $0.18 $227M 2B 303K $0.02

Jacobson Pharma Financials Summary

As of 31-Mar-2026, Jacobson Pharma has a trailing 12-month revenue of $201M.

In Thousands,
USD
TTM 31-Mar-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 382,099 382,099 327,983 211,700
Revenue 201,101 201,101 202,340 187,581
EBITDA 69,039 69,039 69,824 57,650
Net Income 38,647 38,647 38,601 34,118
Total Assets 454,823 454,823 468,602 445,519
Total Debt 116,249 116,249 99,400 95,749
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Jacobson Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Jacobson Pharma‘s full profile, request access.

Request a free trial

Jacobson Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jacobson Pharma Investments & Acquisitions (9)

Jacobson Pharma’s most recent deal was a Secondary Transaction - Private with Xinlejia International for . The deal was made on 21-Nov-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Xinlejia International 21-Nov-2023 Secondary Transaction - Private Media and Information Services (B2B)
Ban Loong Jacobson JBM Pharma 15-Jun-2022 Joint Venture Pharmaceuticals
HMD Dentech 13-Oct-2021 Later Stage VC Distributors (Healthcare)
Cellomics International 24-Sep-2021 Later Stage VC Diagnostic Equipment
HMD Dentech 23-Jan-2020 Early Stage VC Distributors (Healthcare)
You’re viewing 5 of 9 investments and acquisitions. Get the full list »

Jacobson Pharma ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Jacobson Pharma’s complete esg history, request access »

Jacobson Pharma Exits (2)

Jacobson Pharma’s most recent exit was on 21-Nov-2023 from Xinlejia International. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Xinlejia International 21-Nov-2023 Completed
Shanghai Henlius 01-Jan-2018 Later Stage VC Completed
  • 5 buyers
To view Jacobson Pharma’s complete exits history, request access »

Jacobson Pharma FAQs

  • When was Jacobson Pharma founded?

    Jacobson Pharma was founded in 2016.

  • Where is Jacobson Pharma headquartered?

    Jacobson Pharma is headquartered in Hong Kong, Hong Kong.

  • What is the size of Jacobson Pharma?

    Jacobson Pharma has 1,768 total employees.

  • What industry is Jacobson Pharma in?

    Jacobson Pharma’s primary industry is Holding Companies.

  • Is Jacobson Pharma a private or public company?

    Jacobson Pharma is a Public company.

  • What is Jacobson Pharma’s stock symbol?

    The ticker symbol for Jacobson Pharma is 02633.

  • What is the current stock price of Jacobson Pharma?

    As of 20-Nov-2026 the stock price of Jacobson Pharma is $0.11.

  • What is the current market cap of Jacobson Pharma?

    The current market capitalization of Jacobson Pharma is $227M.

  • What is Jacobson Pharma’s current revenue?

    The trailing twelve month revenue for Jacobson Pharma is $201M.

  • What is Jacobson Pharma’s annual earnings per share (EPS)?

    Jacobson Pharma’s EPS for 12 months was $0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process